Loading…
Reported covered position: Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ALLINA HEALTH SYSTEM · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Issues pertaining to H.R. 1 and impact on funding and payment models; Medicare and Medicaid program integrity measures.
Accelerating Kids’ Access to Care Act of 2025
Client: CHILDREN'S HOSPITAL COLORADO · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Accelerating Kids' Access to Care Act (S. 752/H.R. 1509) and the Consolidated Appropriations Act.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
TEVA PHARMACEUTICALS USA, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · third_quarter · Q3
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.
Source: Senate LDA
| CHILDREN'S HOSPITAL COLORADO | 8 | 2025–2026 |
| CIRCLE MEDICAL | 6 | 2023–2024 |
| TURQUOISE HEALTH CO. | 6 | 2024–2025 |
| ALLINA HEALTH SYSTEM | 4 | 2026 |
| THE CHICAGO SCHOOL | 4 | 2025–2026 |
| SSM HEALTH | 2 | 2026 |
| THE NATIONAL SOCIETY OF GENETIC COUNSELORS | 1 | 2024 |
Rebuild America’s Health Care Schools Act of 2025
Client: ALLINA HEALTH SYSTEM · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medicare & Medicaid funding; State Directed Payment issues; S. 1087 and H.R. 1708, the Rebuild Americas Healthcare Schools Act.
Rebuild America’s Health Care Schools Act of 2025
Client: ALLINA HEALTH SYSTEM · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medicare & Medicaid funding; State Directed Payment issues; S. 1087 and H.R. 1708, the Rebuild Americas Healthcare Schools Act.
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform.
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform.
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.
S.1101/H.R. 2332, the SHARE Act; 340B program policy issues; Rural healthcare policies; Issues pertaining to FEMA reimbursement; Extension of expiring health policies; Concerns around negotiated rulemaking changes to professional degrees and impact on nursing programs; Policies to support collaboration with Department of Veterans Affairs.
S.1101/H.R. 2332, the SHARE Act; 340B program policy issues; Rural healthcare policies; Issues pertaining to FEMA reimbursement; Extension of expiring health policies; Policies to support collaboration with Department of Veterans Affairs.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
SAFE Drugs Act of 2025
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2025
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2025
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2025
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2025
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2025
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2025
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2025
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2025
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2025
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2025
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2025
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Rebuild America’s Health Care Schools Act of 2025
Client: ALLINA HEALTH SYSTEM · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medicare & Medicaid funding; State Directed Payment issues; S. 1087 and H.R. 1708, the Rebuild Americas Healthcare Schools Act.
Rebuild America’s Health Care Schools Act of 2025
Client: ALLINA HEALTH SYSTEM · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medicare & Medicaid funding; State Directed Payment issues; S. 1087 and H.R. 1708, the Rebuild Americas Healthcare Schools Act.
Stop STALLING Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform.
Stop STALLING Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.
Stop STALLING Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.
Stop STALLING Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.
Stop STALLING Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform.
Stop STALLING Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.
Preserve Access to Affordable Generics and Biosimilars Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.
Preserve Access to Affordable Generics and Biosimilars Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.
Preserve Access to Affordable Generics and Biosimilars Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform.
Preserve Access to Affordable Generics and Biosimilars Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform.
Preserve Access to Affordable Generics and Biosimilars Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.
Preserve Access to Affordable Generics and Biosimilars Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.
Interagency Patent Coordination and Improvement Act of 2025
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform.
Interagency Patent Coordination and Improvement Act of 2025
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.
Interagency Patent Coordination and Improvement Act of 2025
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.
Interagency Patent Coordination and Improvement Act of 2025
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform.
Interagency Patent Coordination and Improvement Act of 2025
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.
Interagency Patent Coordination and Improvement Act of 2025
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.
S.1101/H.R. 2332, the SHARE Act; 340B program policy issues; Rural healthcare policies; Issues pertaining to FEMA reimbursement; Extension of expiring health policies; Concerns around negotiated rulemaking changes to professional degrees and impact on nursing programs; Policies to support collaboration with Department of Veterans Affairs.
S.1101/H.R. 2332, the SHARE Act; 340B program policy issues; Rural healthcare policies; Issues pertaining to FEMA reimbursement; Extension of expiring health policies; Policies to support collaboration with Department of Veterans Affairs.
GUARD Act
Client: NATIONAL ACADEMY OF ELDER LAW ATTORNEYS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery; Older Americans Act Reauthorization; Elder Justice Act; SNAP funding; GUARD Act (S. 2544); Administration for Community Living funding.
GUARD Act
Client: NATIONAL ACADEMY OF ELDER LAW ATTORNEYS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery; Older Americans Act Reauthorization; Elder Justice Act; SNAP funding; GUARD Act (S. 2544); Administration for Community Living funding.
GUARD Act
Client: NATIONAL ACADEMY OF ELDER LAW ATTORNEYS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery; Older Americans Act Reauthorization; Elder Justice Act; SNAP funding; GUARD Act (S. 2544); Administration for Community Living funding.
SAFE Drugs Act of 2026
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2026
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2026
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2026
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules; CMS DMEPOS accreditation program; S. 3794 SAFE Drugs Act.
SAFE Drugs Act of 2026
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2026
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2026
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2026
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules; CMS DMEPOS accreditation program; S. 3794 SAFE Drugs Act.
SAFE Drugs Act of 2026
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2026
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2026
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2026
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules; CMS DMEPOS accreditation program; S. 3794 SAFE Drugs Act.
SAFE Drugs Act of 2026
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2026
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2026
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
Skinny Labels, Big Savings Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform.
Skinny Labels, Big Savings Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.
Skinny Labels, Big Savings Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.
Skinny Labels, Big Savings Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform.
Skinny Labels, Big Savings Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.
Skinny Labels, Big Savings Act
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.
Accelerating Kids’ Access to Care Act
Client: CHILDREN'S HOSPITAL COLORADO · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Accelerating Kids' Access to Care Act (S. 752/H.R. 1509) and the Consolidated Appropriations Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CHILDREN'S HOSPITAL COLORADO · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Accelerating Kids' Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Reductions in Medicaid funding and changes to provider tax and supplemental payments under H.R. 1, the One Big, Beautiful Bill Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CHILDREN'S HOSPITAL COLORADO · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Accelerating Kids' Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Reductions in Medicaid funding and changes to provider tax and supplemental payments under H.R. 1, the One Big, Beautiful Bill Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CHILDREN'S HOSPITAL COLORADO · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Accelerating Kids' Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Reductions in Medicaid funding and changes to provider tax and supplemental payments under H.R. 1, the One Big, Beautiful Bill Act.
Accelerating Kids’ Access to Care Act of 2025
Client: CHILDREN'S HOSPITAL COLORADO · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Accelerating Kids' Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Reductions in Medicaid funding and changes to provider tax and supplemental payments under H.R. 1, the One Big, Beautiful Bill Act.
Accelerating Kids’ Access to Care Act of 2025
Client: CHILDREN'S HOSPITAL COLORADO · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Accelerating Kids' Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Medicaid funding and budget reconciliation.
Accelerating Kids’ Access to Care Act of 2025
Client: CHILDREN'S HOSPITAL COLORADO · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Accelerating Kids' Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Reductions in Medicaid funding and changes to provider tax and supplemental payments under H.R. 1, the One Big, Beautiful Bill Act.
Accelerating Kids’ Access to Care Act of 2025
Client: CHILDREN'S HOSPITAL COLORADO · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Accelerating Kids' Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Reductions in Medicaid funding and changes to provider tax and supplemental payments under H.R. 1, the One Big, Beautiful Bill Act.
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform.
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform.
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform.
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform.
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs.
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs.
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs.
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: TEVA PHARMACEUTICALS USA, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · third_quarter · Q3
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules; CMS DMEPOS accreditation program; S. 3794 SAFE Drugs Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
SSM HEALTH via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · third_quarter · Q3
S.1101/H.R. 2332, the SHARE Act; 340B program policy issues; Rural healthcare policies; Issues pertaining to FEMA reimbursement; Extension of expiring health policies; Policies to support collaboration with Department of Veterans Affairs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S HOSPITAL COLORADO via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · third_quarter · Q3
Support for pediatric mental health programs, Proposed OMB Regulation for Federal Financial Assistance, legislation relating to online policies and children; Pediatric organ transplantation issues.
Tricare policies pertaining to reimbursement of childrens hospitals for outpatient procedures; National Defense Authorization Act.
FY 27 community project funding
Out-of-state Medicaid access issues and implementation of the Accelerating Kids Access to Care Act
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ALLINA HEALTH SYSTEM via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · third_quarter · Q3
FY 27 community project funding
340B program policies, policies and funding for rural healthcare services including the Rural Health Transformation Fund
Reimbursement for applications for COVID-19 emergency costs
Issues pertaining to FEMA Covid disaster payments.
Medicare & Medicaid funding; State Directed Payment issues; S. 1087 and H.R. 1708, the Rebuild Americas Healthcare Schools Act.
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · third_quarter · Q3
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · second_quarter · Q2
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
THE CHICAGO SCHOOL via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · second_quarter · Q2
RISE Committee negotiated rulemaking on OBBBA graduate student loan changes, support for the inclusion of clinical psychology as a professional degree program; FY27 Congressionally Directed Spending application.
RISE Committee negotiated rulemaking on OBBBA graduate student loan changes, support for the inclusion of clinical psychology as a professional degree program; FY27 Congressionally Directed Spending application.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEVA PHARMACEUTICALS USA, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · second_quarter · Q2
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · second_quarter · Q2
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules; CMS DMEPOS accreditation program; S. 3794 SAFE Drugs Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
SSM HEALTH via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · second_quarter · Q2
S.1101/H.R. 2332, the SHARE Act; 340B program policy issues; Rural healthcare policies; Issues pertaining to FEMA reimbursement; Extension of expiring health policies; Concerns around negotiated rulemaking changes to professional degrees and impact on nursing programs; Policies to support collaboration with Department of Veterans Affairs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S HOSPITAL COLORADO via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · second_quarter · Q2
FY 27 community project funding
Out-of-state Medicaid access issues and implementation of the Accelerating Kids Access to Care Act
Tricare policies pertaining to reimbursement of childrens hospitals for outpatient procedures; National Defense Authorization Act.
ALLINA HEALTH SYSTEM via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · second_quarter · Q2
Issues pertaining to FEMA Covid disaster payments
FY 27 community project funding
340B program policies, policies and funding for rural healthcare services including the Rural Health Transformation Fund
NATIONAL ACADEMY OF ELDER LAW ATTORNEYS via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · first_quarter · 1T
Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery; Older Americans Act Reauthorization; Elder Justice Act; SNAP funding; GUARD Act (S. 2544); Administration for Community Living funding.
Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery; Older Americans Act Reauthorization; Elder Justice Act; SNAP funding; GUARD Act (S. 2544); Administration for Community Living funding.
Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery; Older Americans Act Reauthorization; Elder Justice Act; SNAP funding; GUARD Act (S. 2544); Administration for Community Living funding.
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · first_quarter · Q1
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
CHILDREN'S HOSPITAL COLORADO via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · first_quarter · Q1
Accelerating Kids' Access to Care Act (S. 752/H.R. 1509) and the Consolidated Appropriations Act.
Tricare policies pertaining to reimbursement of childrens hospitals for outpatient procedures; National Defense Authorization Act.
FY 27 community project funding
ALLINA HEALTH SYSTEM via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · first_quarter · Q1
FEMA payments related to COVID response; 340B program; Consolidated Appropriation Act; telehealth policy; healthcare extenders
Issues pertaining to H.R. 1 and impact on funding and payment models; Medicare and Medicaid program integrity measures.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE CHICAGO SCHOOL via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · first_quarter · Q1
RISE Committee negotiated rulemaking on OBBBA graduate student loan changes, support for the inclusion of clinical psychology as a professional degree program; FY27 Congressionally Directed Spending application.
RISE Committee negotiated rulemaking on OBBBA graduate student loan changes, support for the inclusion of clinical psychology as a professional degree program; FY27 Congressionally Directed Spending application.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEVA PHARMACEUTICALS USA, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · first_quarter · Q1
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform.
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · first_quarter · Q1
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules; CMS DMEPOS accreditation program; S. 3794 SAFE Drugs Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
ALLINA HEALTH SYSTEM via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · first_quarter · RR
Issues pertaining to federal healthcare policy and funding including the Medicare and Medicaid programs, 340B, telehealth, workforce/Graduate Medical Education and other issues.
Issues pertaining to federal healthcare policy and funding including the Medicare and Medicaid programs, 340B, telehealth, workforce/Graduate Medical Education and other issues.
NATIONAL ACADEMY OF ELDER LAW ATTORNEYS via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · fourth_quarter · Q4
Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery; Older Americans Act Reauthorization; Elder Justice Act; SNAP funding; GUARD Act (S. 2544); Administration for Community Living funding.
Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery; Older Americans Act Reauthorization; Elder Justice Act; SNAP funding; GUARD Act (S. 2544); Administration for Community Living funding.
Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery; Older Americans Act Reauthorization; Elder Justice Act; SNAP funding; GUARD Act (S. 2544); Administration for Community Living funding.
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · fourth_quarter · Q4
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
THE CHICAGO SCHOOL via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · fourth_quarter · Q4
RISE Committee negotiated rulemaking on OBBBA graduate student loan changes, support for the inclusion of clinical psychology as a professional degree program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TURQUOISE HEALTH CO. via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · fourth_quarter · Q4
Support health care price transparency legislation (S. 2355 Patients Deserve Price Tags Act and S. 2420/HR 4710 No Surprises Act Enforcement Act); Support PBM transparency legislation.
Support health care price transparency legislation (S. 2355 Patients Deserve Price Tags Act and S. 2420/HR 4710 No Surprises Act Enforcement Act); Support PBM transparency legislation.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TEVA PHARMACEUTICALS USA, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · fourth_quarter · Q4
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform.
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · fourth_quarter · Q4
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
CHILDREN'S HOSPITAL COLORADO via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · fourth_quarter · Q4
Federal indirect cost issues pertaining to National Institutes of Health funding; NIH structural issues pertaining to pediatric research; Make America Healthy Again activities; Healthcare workforce issues including the Children's Hospital Graduate Medical Education (CHGME) program; Healthcare workforce and related issues.
Accelerating Kids' Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Reductions in Medicaid funding and changes to provider tax and supplemental payments under H.R. 1, the One Big, Beautiful Bill Act.
THE CHICAGO SCHOOL via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · fourth_quarter · RR
Federal loan and grant support for higher education (GRAD PLUS loans, TRIO, etc); Mental and behavioral health workforce issues
Federal loan and grant support for higher education (GRAD PLUS loans, TRIO, etc); Mental and behavioral health workforce issues
TURQUOISE HEALTH CO. via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · third_quarter · Q3
Support health care price transparency legislation (S. 2355 Patients Deserve Price Tags Act and S. 2420/HR 4710 No Surprises Act Enforcement Act); Support PBM transparency legislation.
Support health care price transparency legislation (S. 2355 Patients Deserve Price Tags Act and S. 2420/HR 4710 No Surprises Act Enforcement Act); Support PBM transparency legislation.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TEVA PHARMACEUTICALS USA, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · third_quarter · Q3
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform.
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · third_quarter · Q3
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S HOSPITAL COLORADO via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · third_quarter · Q3
Federal indirect cost issues pertaining to National Institutes of Health funding; NIH structural issues pertaining to pediatric research; Make America Healthy Again activities; Healthcare workforce issues including the Children's Hospital Graduate Medical Education (CHGME) program.
Accelerating Kids' Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Reductions in Medicaid funding and changes to provider tax and supplemental payments under H.R. 1, the One Big, Beautiful Bill Act.
Tricare policies pertaining to reimbursement of childrens hospitals for outpatient procedures; National Defense Authorization Act.
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · third_quarter · Q3
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
NATIONAL ACADEMY OF ELDER LAW ATTORNEYS via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · third_quarter · Q3
Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery; Older Americans Act Reauthorization; Elder Justice Act; SNAP funding; GUARD Act (S. 2544); Administration for Community Living funding.
Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery; Older Americans Act Reauthorization; Elder Justice Act; SNAP funding; GUARD Act (S. 2544); Administration for Community Living funding.
Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery; Older Americans Act Reauthorization; Elder Justice Act; SNAP funding; GUARD Act (S. 2544); Administration for Community Living funding.
WHOLESALE & SPECIALTY INSURANCE ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · second_quarter · Q2
Issues related to extension of the National Flood Insurance Program; enactment of a safe harbor for insurers of state-legal cannabis businesses; Establishment of the National Association of Registered Agents & Brokers board; Issues related to establishing a safe harbor for insurance companies to provide services to state-legal cannabis operations; H.R. 3437/S. 1544, the Insurance Data Protection Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ACADEMY OF ELDER LAW ATTORNEYS via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · second_quarter · Q2
Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery
Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery
Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery
Filing targets: HOUSE OF REPRESENTATIVES
TURQUOISE HEALTH CO. via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · second_quarter · Q2
Support health care price transparency and PBM reform legislation.
Support health care price transparency and PBM reform legislation.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TEVA PHARMACEUTICALS USA, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · second_quarter · Q2
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs.
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · second_quarter · Q2
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · second_quarter · Q2
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
CHILDREN'S HOSPITAL COLORADO via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · second_quarter · Q2
Federal indirect cost issues pertaining to National Institutes of Health funding; NIH structural issues pertaining to pediatric research; Make America Healthy Again activities.
Accelerating Kids' Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Reductions in Medicaid funding and changes to provider tax and supplemental payments under H.R. 1, the One Big, Beautiful Bill Act.
Tricare policies pertaining to reimbursement of childrens hospitals for outpatient procedures; National Defense Authorization Act.
WHOLESALE & SPECIALTY INSURANCE ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · first_quarter · Q1
Issues related to extension of the National Flood Insurance Program; enactment of a safe harbor for insurers of state-legal cannabis businesses; Establishment of the National Association of Registered Agents & Brokers board; Issues related to establishing a safe harbor for insurance companies to provide services to state-legal cannabis operations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEVA PHARMACEUTICALS USA, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · first_quarter · Q1
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs.
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ACADEMY OF ELDER LAW ATTORNEYS via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · first_quarter · Q1
Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery
Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery
Filing targets: HOUSE OF REPRESENTATIVES
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · first_quarter · Q1
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
TURQUOISE HEALTH CO. via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · first_quarter · Q1
Support health care price transparency and PBM reform legislation.
Support health care price transparency and PBM reform legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · first_quarter · Q1
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S HOSPITAL COLORADO via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · first_quarter · Q1
Changes to NIH calculation of F&A rates; Make America Healthy Again Executive Order and Commission (includes HHS/OS). Child health and well-being and child health research issues and needs.
Accelerating Kids' Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Medicaid funding and budget reconciliation.
Tricare policies regarding outpatient reimbursement of children's hospitals.
Filing targets: Health & Human Services, Dept of (HHS)
CHILDREN'S HOSPITAL COLORADO via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · first_quarter · RR
Topics likely to include Medicaid, pediatric medical research, government funding, and coverage of children within the Tricare program, among others.
Topics likely to include Medicaid, pediatric medical research, government funding, and coverage of children within the Tricare program, among others.
Topics likely to include Medicaid, pediatric medical research, government funding, and coverage of children within the Tricare program, among others.
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · fourth_quarter · Q4
WHOIS; Communications Decency Act; Section 230 reform; S. 4858 - Cooper Davis Act.
S. 936 - The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers (INFORM Consumers) Act of 2021; H.R. 3429 - the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act of 2021; S. 4858 - Cooper Davis Act.
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Domain Reform for Unlawful Drug Sellers Act (DRUGS Act); SHOP SAFE Act; S. 1080 - Cooper Davis Act.
TURQUOISE HEALTH CO. via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · fourth_quarter · Q4
HR 5378 Lower Costs, More Transparency, S 3548 Health Care Prices Revealed and Information to Consumers Explained (PRICE) Transparency Act, and HR 9572 Enhanced Enforcement of Health Coverage Act.
HR 5378 Lower Costs, More Transparency, S 3548 Health Care Prices Revealed and Information to Consumers Explained (PRICE) Transparency Act, and HR 9572 Enhanced Enforcement of Health Coverage Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEVA PHARMACEUTICALS USA, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · fourth_quarter · Q4
Changes to Hatch-Waxman's 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals. Implementation of the Inflation Reduction Act. Drug pricing proposals. Oversight and reform efforts affecting pharmacy benefit managers, including Pharmacy Benefit Manager Transparency Act (S. 127), Prescription Pricing for the People Act (S. 113), and Drug Price Transparency in Medicaid Act of 2023 (H.R. 1613), and Lower Costs, More Transparency Act (H.R. 5378); Patent reform, including the Preserve Access to Affordable Generics and Biosimilars Act (S. 142), Affordable Prescriptions for Patients Act (S. 150); Block, Report, and Suspend Suspicious Shipments Act (H.R. 501); Proposal related to drug shortages.
Changes to Hatch-Waxman's 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals. Implementation of the Inflation Reduction Act. Drug pricing proposals. Oversight and reform efforts affecting pharmacy benefit managers, including Pharmacy Benefit Manager Transparency Act (S. 127), Prescription Pricing for the People Act (S. 113), and Drug Price Transparency in Medicaid Act of 2023 (H.R. 1613), and Lower Costs, More Transparency Act (H.R. 5378); Patent reform, including the Preserve Access to Affordable Generics and Biosimilars Act (S. 142), Affordable Prescriptions for Patients Act (S. 150); Block, Report, and Suspend Suspicious Shipments Act (H.R. 501); Proposal related to drug shortages.
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · fourth_quarter · Q4
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 9886/S. 5271 BUPE for Recovery Act and H.R. 5526 Seniors Access to Critical Medications Act.
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 9886/S.5271 BUPE for Recovery Act and H.R. 5526 Seniors' Access to Critical Medications Act.
WHOLESALE & SPECIALTY INSURANCE ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · fourth_quarter · Q4
Issues related to extension of the National Flood Insurance Program; enactment of a safe harbor for insurers of state-legal cannabis businesses; Establishment of the National Association of Registered Agents & Brokers board; issues related to S. 2860, the SAFER Banking Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE NATIONAL SOCIETY OF GENETIC COUNSELORS via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · fourth_quarter · RR
H.R. 3876/S. 2323 Access to Genetic Counselor Services Act.
H.R. 3876/S. 2323 Access to Genetic Counselor Services Act.
WHOLESALE & SPECIALTY INSURANCE ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · third_quarter · Q3
Issues related to extension of the National Flood Insurance Program; enactment of a safe harbor for insurers of state-legal cannabis businesses; Establishment of the National Association of Registered Agents & Brokers board; issues related to S. 2860, the SAFER Banking Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, White House Office
NATIONAL ACADEMY OF ELDER LAW ATTORNEYS via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · third_quarter · Q3
Home and Community-Based Services (HCBS); Guardianship; Medicaid; Social Security; PHE unwinding; H.R. 7573; Stop Unfair Medicaid Recoveries Act; H.R. 8019; Money Follows the Person Permanency Act of 2024; H.R. 8110, Protecting Married Seniors from Impoverishment Act of 2024.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · third_quarter · Q3
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Domain Reform for Unlawful Drug Sellers Act (DRUGS Act); SHOP SAFE Act; S. 1080 - Cooper Davis Act.
WHOIS; Communications Decency Act; Section 230 reform; S. 4858 - Cooper Davis Act.
S. 936 - The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers (INFORM Consumers) Act of 2021; H.R. 3429 - the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act of 2021; S. 4858 - Cooper Davis Act.
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · third_quarter · Q3
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act.
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act.
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
ATA ACTION via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · third_quarter · Q3
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act; Telehealth Modernization Act, Primary and Virtual Care Affordability Act, Expanding Remote Monitoring Access Act; Preserving Telehealth, Hospital, and Ambulance Access Act (HR 6364); Expanding Remote Monitoring Access Act (HR 53934); Sustainable Cardiopulmonary Rehabilitation (CR) Service in the Home Act (HR 1406).
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act; TREATS Act; Ryan Haight Act/DEA rulemaking on telemedicine: H.R. 1843, S. 1001 - Telehealth Expansion Act; H.R. 824 Telehealth Benefit Expansion for Workers Act; Telehealth Modernization Act, Primary and Virtual Care Affordability Act, Expanding Remote Monitoring Access Act
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TURQUOISE HEALTH CO. via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · third_quarter · RR
Price transparency: H.R. 5378 Lower Costs, More Transparency Act, S.3430 Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023, S. 3548 Health Care Prices Revealed and Information to Consumers Explained (PRICE) Transparency Act
Price transparency: H.R. 5378 Lower Costs, More Transparency Act, S.3430 Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023, S. 3548 Health Care Prices Revealed and Information to Consumers Explained (PRICE) Transparency Act
TEVA PHARMACEUTICALS USA, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · second_quarter · RR
Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals. Implementation of the Inflation Reduction Act. Drug pricing proposals. Oversight and reform efforts affecting pharmacy benefit managers, including Pharmacy Benefit Manager Transparency Act (S. 127), Prescription Pricing for the People Act (S. 113), and Drug Price Transparency in Medicaid Act of 2023 (H.R. 1613), and Lower Costs, More Transparency Act (H.R. 5378). Patent reform, including the Preserve Access to Affordable Generics and Biosimilars Act (S.142), Affordable Prescriptions for Patients Act (S.150). Block, Report, and Suspend Suspicious Shipments Act (H.R. 501). Proposals related to drug shortages.
Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals. Implementation of the Inflation Reduction Act. Drug pricing proposals. Oversight and reform efforts affecting pharmacy benefit managers, including Pharmacy Benefit Manager Transparency Act (S. 127), Prescription Pricing for the People Act (S. 113), and Drug Price Transparency in Medicaid Act of 2023 (H.R. 1613), and Lower Costs, More Transparency Act (H.R. 5378). Patent reform, including the Preserve Access to Affordable Generics and Biosimilars Act (S.142), Affordable Prescriptions for Patients Act (S.150). Block, Report, and Suspend Suspicious Shipments Act (H.R. 501). Proposals related to drug shortages.
CIRCLE MEDICAL via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · second_quarter · 2T
Issues related to telehealth/telemedicine and pharmacies.
Issues related to telehealth/telemedicine, prescribing, and pharmacy dispensing of medications.
Filing targets: Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office
WHOLESALE & SPECIALTY INSURANCE ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · second_quarter · Q2
Issues related to extension of the National Flood Insurance Program; enactment of a safe harbor for insurers of state-legal cannabis businesses; Establishment of the National Association of Registered Agents & Brokers board; issues related to S. 2860, the SAFER Banking Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, White House Office
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · second_quarter · Q2
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
ATA ACTION via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · second_quarter · Q2
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act; TREATS Act; Ryan Haight Act/DEA rulemaking on telemedicine: H.R. 1843, S. 1001 - Telehealth Expansion Act; H.R. 824 Telehealth Benefit Expansion for Workers Act; Telehealth Modernization Act, Primary and Virtual Care Affordability Act, Expanding Remote Monitoring Access Act
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act; Telehealth Modernization Act, Primary and Virtual Care Affordability Act, Expanding Remote Monitoring Access Act; Preserving Telehealth, Hospital, and Ambulance Access Act (HR 6364); Expanding Remote Monitoring Access Act (HR 53934); Sustainable Cardiopulmonary Rehabilitation (CR) Service in the Home Act (HR 1406).
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · second_quarter · Q2
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act);S. 1843, H.R. 3429 - SHOPSAFE Act; S. 4858 - Cooper Davis Act.
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Domain Reform for Unlawful Drug Sellers Act (DRUGS Act); SHOP SAFE Act; S. 1080 - Cooper Davis Act.
NATIONAL ACADEMY OF ELDER LAW ATTORNEYS via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · second_quarter · Q2
Home and Community-Based Services (HCBS); Guardianship; Medicaid; Social Security; PHE unwinding; H.R. 7573; Stop Unfair Medicaid Recoveries Act; H.R. 8019; Money Follows the Person Permanency Act of 2024; H.R. 8110, Protecting Married Seniors from Impoverishment Act of 2024.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · first_quarter · Q1
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
WHOLESALE & SPECIALTY INSURANCE ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · first_quarter · Q1
Issues related to extension of the National Flood Insurance Program; enactment of a safe harbor for insurers of state-legal cannabis businesses; Establishment of the National Association of Registered Agents & Brokers board; issues related to S. 2860, the SAFER Banking Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
CIRCLE MEDICAL via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · first_quarter · Q1
Issues related to telehealth/telemedicine, prescribing, and pharmacy dispensing of medications.
Issues related to telehealth/telemedicine and pharmacies.
Filing targets: Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office
ATA ACTION via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · first_quarter · Q1
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act; Telehealth Modernization Act, Primary and Virtual Care Affordability Act, Expanding Remote Monitoring Access Act
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act; TREATS Act; Ryan Haight Act/DEA rulemaking on telemedicine: H.R. 1843, S. 1001 - Telehealth Expansion Act; H.R. 824 Telehealth Benefit Expansion for Workers Act; Telehealth Modernization Act, Primary and Virtual Care Affordability Act, Expanding Remote Monitoring Access Act
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · first_quarter · Q1
S. 936 - The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers (INFORM Consumers) Act of 2021; H.R. 3429 - the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act of 2021; S. 4858 - Cooper Davis Act.
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Domain Reform for Unlawful Drug Sellers Act (DRUGS Act); SHOP SAFE Act; S. 1080 - Cooper Davis Act.
NATIONAL ACADEMY OF ELDER LAW ATTORNEYS via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · first_quarter · Q1
Home and Community-Based Services (HCBS); Guardianship; Medicaid; Social Security; PHE unwinding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WHOLESALE & SPECIALTY INSURANCE ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · fourth_quarter · 4A
Issues related to extension of the National Flood Insurance Program; enactment of a safe harbor for insurers of state-legal cannabis businesses; Establishment of the National Association of Registered Agents & Brokers board; issues related to S. 2860, the SAFER Banking Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
WHOLESALE & SPECIALTY INSURANCE ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · fourth_quarter · 4A
Issues related to extension of the National Flood Insurance Program; enactment of a safe harbor for insurers of state-legal cannabis businesses; Establishment of the National Association of Registered Agents & Brokers board; issues related to S. 2860, the SAFER Banking Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
CIRCLE MEDICAL via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · fourth_quarter · Q4
Issues related to telehealth/telemedicine and pharmacies.
Issues related to telehealth/telemedicine, prescribing, and pharmacy dispensing of medications.
Filing targets: Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office
ATA ACTION via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · fourth_quarter · Q4
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act.
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act; TREATS Act; Ryan Haight Act/DEA rulemaking on telemedicine; H.R. 1843, S. 1001 - Telehealth Expansion Act; H.R. 824 Telehealth Benefit Expansion for Workers Act.
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · fourth_quarter · Q4
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Domain Reform for Unlawful Drug Sellers Act (DRUGS Act); SHOP SAFE Act; S. 1080 - Cooper Davis Act.
S. 936 - The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers (INFORM Consumers) Act of 2021; H.R. 3429 - the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act of 2021; S. 4858 - Cooper Davis Act.
NATIONAL ACADEMY OF ELDER LAW ATTORNEYS via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · fourth_quarter · Q4
Home and Community-Based Services (HCBS); Guardianship; Medicaid; Social Security; PHE unwinding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · fourth_quarter · Q4
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/ S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/ S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
ATA ACTION via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · third_quarter · Q3
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act.
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act; TREATS Act; Ryan Haight Act/DEA rulemaking on telemedicine; H.R. 1843, S. 1001 - Telehealth Expansion Act; H.R. 824 Telehealth Benefit Expansion for Workers Act.
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
WHOLESALE & SPECIALTY INSURANCE ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · third_quarter · Q3
Issues related to extension of the National Flood Insurance Program; enactment of a safe harbor for insurers of state-legal cannabis businesses; Establishment of the National Association of Registered Agents & Brokers board; issues related to S. 2860, the SAFER Banking Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · third_quarter · Q3
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth.
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth.
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
CIRCLE MEDICAL via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · third_quarter · Q3
Issues related to telehealth/telemedicine, prescribing, and pharmacy dispensing of medications.
Issues related to telehealth/telemedicine and pharmacies.
Filing targets: HOUSE OF REPRESENTATIVES
NATIONAL ACADEMY OF ELDER LAW ATTORNEYS via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · third_quarter · Q3
Home and Community-Based Services (HCBS), Guardianship; Medicaid; PHE unwinding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · third_quarter · Q3
S. 936 - The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers (INFORM Consumers) Act of 2021; H.R. 3429 - the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act of 2021; S. 4858 - Cooper Davis Act.
WHOIS; Communications Decency Act; Section 230 reform; S. 4858 - Cooper Davis Act.
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act);S. 1843, H.R. 3429 - SHOPSAFE Act; S. 4858 - Cooper Davis Act.
CIRCLE MEDICAL via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · second_quarter · Q2
Issues related to telehealth/telemedicine, prescribing, and pharmacy dispensing of medications.
Issues related to telehealth/telemedicine and pharmacies.
Filing targets: HOUSE OF REPRESENTATIVES
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · second_quarter · Q2
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act);S. 1843, H.R. 3429 - SHOPSAFE Act; S. 4858 - Cooper Davis Act.
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Domain Reform for Unlawful Drug Sellers Act (DRUGS Act); SHOP SAFE Act; S. 1080 - Cooper Davis Act.
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · second_quarter · Q2
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth.
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth.
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
ATA ACTION via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · second_quarter · Q2
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act; TREATS Act; Ryan Haight Act/DEA rulemaking on telemedicine; H.R. 1843, S. 1001 - Telehealth Expansion Act; H.R. 824 Telehealth Benefit Expansion for Workers Act.
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act.
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
WHOLESALE & SPECIALTY INSURANCE ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · second_quarter · Q2
Issues related to extension of the National Flood Insurance Program; enactment of a safe harbor for insurers of state-legal cannabis businesses; Establishment of the National Association of Registered Agents & Brokers board.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
NATIONAL ACADEMY OF ELDER LAW ATTORNEYS via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · second_quarter · Q2
Home and Community-Based Services (HCBS), Guardianship; Medicaid; PHE unwinding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
NATIONAL ACADEMY OF ELDER LAW ATTORNEYS via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · first_quarter · Q1
Home and Community-Based Services (HCBS), Guardianship; Medicaid; PHE unwinding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · first_quarter · Q1
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth.
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth.
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
ATA ACTION via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · first_quarter · Q1
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act; TREATS Act; Ryan Haight Act/DEA rulemaking on telemedicine; H.R. 1843, S. 1001 - Telehealth Expansion Act; H.R. 824 Telehealth Benefit Expansion for Workers Act.
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act.
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · first_quarter · Q1
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act);S. 1843, H.R. 3429 - SHOPSAFE Act; S. 4858 - Cooper Davis Act.
S. 936 - The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers (INFORM Consumers) Act of 2021; H.R. 3429 - the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act of 2021; S. 4858 - Cooper Davis Act.
WHOLESALE & SPECIALTY INSURANCE ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · first_quarter · Q1
Issues related to extension of the National Flood Insurance Program; enactment of a safe harbor for insurers of state-legal cannabis businesses.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
CIRCLE MEDICAL via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · first_quarter · RR
Issues related to telehealth/telemedicine and pharmacies.
Issues related to telehealth/telemedicine and pharmacies.
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
Policies to improve how NIH supports child health research, support for pediatric mental health programs, Proposed OMB Regulation for Federal Financial Assistance, legislation relating to online policies and children.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Medicare & Medicaid funding; State Directed Payment issues; S. 1087 and H.R. 1708, the Rebuild Americas Healthcare Schools Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Federal indirect cost issues pertaining to National Institutes of Health funding; NIH structural issues pertaining to pediatric research; Make America Healthy Again activities; Healthcare workforce issues including the Children's Hospital Graduate Medical Education (CHGME) program and legislation pertaining to licensure compact issues.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Tricare policies pertaining to reimbursement of childrens hospitals for outpatient procedures; National Defense Authorization Act.
FY 26 funding for the Childrens Hospital Graduate Medical Education program; FY 26 funding for NIH.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
FY 26 funding for the Childrens Hospital Graduate Medical Education program; FY 26 funding for NIH.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FY 26 funding for the Childrens Hospital Graduate Medical Education program; FY 26 funding for NIH.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Topics likely to include Medicaid, pediatric medical research, government funding, and coverage of children within the Tricare program, among others.
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act);S. 1843, H.R. 3429 - SHOPSAFE Act; S. 4858 - Cooper Davis Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act);S. 1843, H.R. 3429 - SHOPSAFE Act; S. 4858 - Cooper Davis Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WHOIS; Communications Decency Act; Section 230 reform; S. 4858 - Cooper Davis Act.
S. 936 - The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers (INFORM Consumers) Act of 2021; H.R. 3429 - the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act of 2021; S. 4858 - Cooper Davis Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WHOIS; Communications Decency Act; Section 230 reform; S. 4858 - Cooper Davis Act.
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act);S. 1843, H.R. 3429 - SHOPSAFE Act; S. 4858 - Cooper Davis Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act);S. 1843, H.R. 3429 - SHOPSAFE Act; S. 4858 - Cooper Davis Act.
WHOIS; Communications Decency Act; Section 230 reform; S. 4858 - Cooper Davis Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Domain Reform for Unlawful Drug Sellers Act (DRUGS Act); SHOP SAFE Act; S. 1080 - Cooper Davis Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WHOIS; Communications Decency Act; Section 230 reform; S. 4858 - Cooper Davis Act.
S. 936 - The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers (INFORM Consumers) Act of 2021; H.R. 3429 - the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act of 2021; S. 4858 - Cooper Davis Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WHOIS; Communications Decency Act; Section 230 reform; S. 4858 - Cooper Davis Act.
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act);S. 1843, H.R. 3429 -SHOP SAFE Act; S. 4858 - Cooper Davis Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE